.

Client Alert

Biden Administration Revises and Expands Restrictions on U.S. Person Investment in Chinese Companies and Releases New List of “Chinese Military Companies” Under 2021 NDAA Section 1260H

June 10, 2021

by Lawrence Ward, Catherine X. Pan-Giordano, Dave Townsend, and T. Augustine Lo

Download as a PDF

Share this page

 

The Biden Administration last week substantially modified restrictions on U.S. person investments in certain Chinese companies, focusing those new restrictions particularly on entities with ties to the Chinese defense or surveillance technology sectors.  President Biden’s new June 3, 2021 Executive Order 14032 (“EO 14032”) expanded earlier executive restrictions in some respects while also eliminating some previous prohibitions targeting certain Chinese companies that were put in place at the end of the Trump Administration.  At the same time, the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) created and published a new Non-SDN Chinese Military-Industrial Complex Companies List (“NS-CMIC List”) under EO 14032.

U.S. financial institutions, brokerage firms, exchanges, and investors will now all need to assess whether they hold “publicly traded securities” of any of the 59 named Chinese entities on the new OFAC NS-CMIC List.  EO 14032 defines the term “publicly traded securities” by adopting the definition of that term under the Securities Exchange Act of 1934, which also includes a variety of investment vehicles such as calls, swaps, exchange traded funds, index funds, mutual funds, options, privileges related to a foreign currency, and others.  Under EO 14032, the same prohibition extends to “any publicly traded securities that are derivative of such securities or are designed to provide investment exposure to such securities.”  OFAC notes that “market makers” or intermediaries in securities trading will also be subject to EO 14032.  U.S. persons can only buy and sell such “publicly traded securities” of the 59 entities on the initial NS-CMIC List until 12:01 am on August 2, 2021 (U.S. Eastern Time).  After that date, U.S. persons will no longer be able to purchase the publicly traded securities of these 59 entities and will only be able to divest such securities until 12:01 am on June 3, 2022 (U.S. Eastern Time).  (For any Chinese entity subsequently added to the NS-CMIC List, the prohibition will apply to its publicly traded securities 60 days after such listing, and divestment will be permissible until 365 days after such listing.)

OFAC’s initial NS-CMIC List includes many large and well-known Chinese companies such as China National Offshore Oil Corporation, China Mobile Limited, China Shipbuilding Industry Company Limited, Huawei, and Semiconductor Manufacturing International Corporation (“SMIC”).  EO 14032 also authorizes OFAC in its discretion to add more such entities in China’s defense or surveillance technology sectors to the NS-CMIC List but does not define exactly what is considered within those industrial sectors.  The White House stated that EO 14032 will allow targeting of Chinese companies that undermine U.S. “security or values of the United States and our allies” and the Biden Administration will consider adding companies involved in China’s defense, intelligence and other security research and development sectors and also entities that develop or use Chinese surveillance technology in ways that abuse human rights.

Separately, the U.S. Department of Defense (“DoD”) also released on June 3, 2021 its own new list of “Chinese Military Companies” as required by Congress in Section 1260H of the National Defense Authorization Act (“NDAA”) of 2021 (“Section 1260H”).

 

Background Legislation, Earlier Executive Order & Lawsuits

Beginning more than 20 years ago, Congress directed the DoD to publish a public list of “Communist Chinese Military Companies” (“CCMCs”) under Section 1237 of the NDAA of 1999, as amended (“Section 1237”).  The criterion set by Congress in Section 1237 was that, to be named as a CCMC, DoD, in conjunction with other elements of the U.S. defense and intelligence community, had to find a company was owned or controlled by the People’s Liberation Army (“PLA”) or by other parts of China’s defense or intelligence establishment, or be owned or controlled by an entity affiliated with the defense industrial base of China.  For some two decades, DoD failed to produce such a Section 1237 List.  However, finally, between June 2020 and January 2021, under Section 1237, DoD designated a total of 44 such CCMCs in five tranches.

As we had previously reported based on the DoD’s issuance of its Section 1237 List, the Trump Administration then issued Executive Order 13959 (“EO 13959”) on November 12, 2020  to restrict U.S. persons from investing in any CCMC named by DoD under Section 1237.  As Congress had envisioned under Section 1237, DoD took the lead in selecting and designating CCMCs, but the Trump Administration tasked a different agency in a separate Cabinet department, OFAC within the Department of the Treasury, to implement EO 13959’s investment restrictions, and that division of roles led to some considerable confusion between those two federal agencies.

For example, there are multiple Chinese companies with publicly traded securities that had close but not exact matches to entity names on DoD’s CCMC List, and it was also unclear whether a CCMC designation by DoD would then apply to every subsidiary that is owned or controlled by a named CCMC entity.  Given such legal confusion, three Chinese companies chose to challenge their Section 1237 designations in federal court lawsuits before the U.S. District Court for the District of Columbia.  Two of those, Xiaomi Corporation and Luokung Technology, obtained a favorable judicial finding in March and May 2021, respectively, that there were fundamental problems with DoD’s Section 1237 designations and the related capital markets restrictions under EO 13959. 

 

Comparison & Contrasts Between EO 13959 and EO 14032

For all practical purposes, President Biden’s EO 14032 amends and largely replaces President Trump’s EO 13959.  EO 14032 retains EO 13959’s declaration of a national emergency related to China’s “military-civil fusion” strategy and the potential ability of Chinese companies to assist the PLA, but EO 14032 also expands the scope of the declared national emergency to include China’s “surveillance technology outside of” China and the use of such technology to suppress human rights, whether inside China or elsewhere in the world.  Finally, EO 14032 sought to cure some of the regulatory confusion that had been caused by EO 13959 applying OFAC’s financial sanctions against transactions involving publicly traded securities of entities on DoD’s Section 1237 List.

Among the differences between these two Trump and Biden Executive Orders are these factors:

Designating Agency: Under EO 14032, OFAC will now itself designate all the entities named to its own NS-CIMC List instead of being bound by DoD’s designations in the Section 1237 List as had been required under EO 13959, and, conversely, being an entity named by DoD to its Section 1237 List will now no longer automatically carry any economic consequences for that entity;

Basis for Designation: Under EO 14032, OFAC can apply its capital markets sanctions against any Chinese company in either the defense or surveillance technology sectors of the Chinese economy instead of being limited to Chinese companies that meet the narrower PLA and defense industrial base ownership or control standards required of NDAA Section 1237 under EO 13959;

Clarity on “Publicly Traded Securities”: Under EO 14032, OFAC will apply the same commonly understood definition of “publicly traded securities” as the U.S. Securities and Exchange Commission (“SEC”) applies under the Securities Exchange Act of 1934, as amended, instead of using a definition of that key term under EO 13959 that appeared to be significantly broader in scope than the SEC’s definition;

Affected Chinese Companies: Under EO 14032, it is expressly stated that only those “publicly traded securities” of a company whose name is an exact match with a company name on OFAC’s NS-CMIC List will be covered by EO 14032’s capital markets sanctions instead of the ambiguity as to such close-but-not-exact name matches to names on DoD’s Section 1237 List under EO 13959; and

Clarity on “50% Rule” Concerns Under OFAC Sanction Regimes: Under EO 14032, a company that is 50% or more owned by a named company on the NS-CMIC List will not automatically be covered by EO 14032 unless and until OFAC expressly adds that entity to the NS-CMIC List, and U.S. persons will then be given a 60-day transition period to adjust their holdings of such “publicly traded securities” of such an affiliate.

 

Yet Another DoD List

In addition, under Section 1260H of the NDAA of 2021, Congress recently mandated that the President must identify by April 15, 2021 and then annually thereafter all “Chinese military companies” (“CMCs”) operating within the United States that DoD has associated with China’s “military-civil fusion” strategy.  Section 1260H provides that, to be so categorized as a CMC, an entity must be either directly or indirectly owned, controlled, or beneficially owned by, or in an official or unofficial capacity acting as an agent of or on behalf of, the PLA or any other organization subordinate to the Central Military Commission of the Chinese Communist Party; or identified as a military-civil fusion contributor to the Chinese defense industrial base and engaged in providing commercial services, manufacturing, producing, or exporting.  (In assigning this new list-generating responsibility to DoD, Congress has also kept in place its previous requirement for the Section 1237 List.)

On June 3, DoD released its new list of Section 1260H designations for 47 CMCs (“Section 1260H List”).  Upon closer review, 39 of those 47 CMCs are also found on the Annex to President Biden’s EO 14032 (and there is significant overlap with the previous Section 1237 List).  Moreover, all eight of the other CMCs named by DoD appear to be corporate affiliates of SMIC, which itself had already been named in the Annex.  However, as of this article’s publication date, it is unclear what further consequences may attach to the 47 CMCs being named to the new Section 1260H List.  For example, if the Biden Administration wishes to apply EO 14032’s capital markets sanctions to a CMC on DoD’s new Section 1260H List, then OFAC will need to act separately to add that company to its own NS-CIMC List, which differs from the previous methodology under EO 13959 that would have automatically triggered such a consequence as soon as a Chinese company were added to the DoD’s Section 1237 List.

 

Further Considerations

The Biden Administration has said that its economic, trade and national security policies towards China are undergoing a comprehensive review by newly confirmed senior officials at the U.S. Departments of State, Defense and Commerce, the Office of the U.S. Trade Representative and the National Security Council, among others.  Since taking office on January 20, 2021, the Administration has initiated several key shifts in regulatory policy through the Commerce Department’s Bureau of Industry and Security (“BIS”) that affect the exports of U.S.-origin goods, software or technology to various Chinese companies and that will soon also affect the import of Chinese-origin goods, software or technology in “information communications technology services” (“ICTS”).

During their individual confirmation hearings, most of these key Biden Administration nominees told skeptical U.S. Senators that they were all committed to “being tough on China,” including with respect to U.S. equity investments in Chinese companies.  In addition, Congress is currently considering a veritable “tsunami of legislation” targeting China (to use the recent description of the U.S.-China Business Council), including new measures that could further expand restrictions on U.S. person investment in Chinese companies or otherwise affect U.S.-China business relationships.  For example, on June 8, the U.S. Senate voted to approve the Endless Frontiers Act, S. 1260, with strong bipartisan support, 68 – 32.  This legislation would expend about $250 billion and encompasses some 2,400 pages of new legal requirements and restrictions, many of which will affect U.S.-China business relationships.  That massive bill is expected to be taken up by the House of Representatives later this year.

It remains to be seen if any of these new laws being debated in Congress will add yet further “lists” to be reviewed.  However, these recent regulatory changes by the Biden Administration show that corporate trade compliance personnel will need to work even more closely with their supply chain planning and marketing and sales colleagues to remain current with the multiple government lists of designated entities in China now being produced among the several lead federal agencies, as shown in the summary table below.  Moreover, the multiplication of these lists, each with its own nuanced legal consequences, will require more internally coordinated business processes and the adoption and use of automated screening software tools in more companies that will be able to receive real-time updates to these U.S. Government lists and to alert compliance personnel of such changes or additions (or removals) on a timely basis.

 

U.S. GOVERNMENT LISTS OF CHINESE COMPANIES (JUNE 2021) 
 Authorization Agency  List 
Sec. 1237, 1999 NDAA  DoD Section 1237 List 
Sec. 1260H, 2021 NDAA  DoD  Section 1260H List 
Appendix A to Part V of Title 31 of the CFR  OFAC  Specially Designated Nationals (SDN) List 
EO 14032  OFAC  NS-CIMC List 
Supp. No. 4, Part 744, EAR  BIS  Entity List 
Supp. No. 1, Part 764, EAR  BIS  Denied Persons List 
Supp. No. 6, Part 744, EAR  BIS  Unverified List 
Supp. No. 7, Part 744, EAR  BIS  Military End User (MEU) List 
Sec. 744.22(f)(2), EAR  BIS

Military-Intelligence End User

(MIEU) List

 

Dorsey’s trade lawyers is able to help with such trade compliance issues.  Please do not hesitate to reach out to attorneys linked with this e-Update for further information.

 

Firm Highlights

News

Dorsey & Whitney Advises Beijing Xunzhong on Two Consecutive H Share Placings Raising HK$418.5 Million

International law firm Dorsey & Whitney LLP acted as Hong Kong legal advisors to Beijing Xunzhong Communication Technology Co., Ltd. (“Xunzhong”) as to Hong Kong law in connection with two consecutive placings of new H shares under general mandate (the “First Placing” and the “Second Placing”, respectively, and together, the “Placings”). Xunzhong’s H shares are listed on the Main Board of the Hong Kong Stock Exchange (Stock Code: 2597). Winbull Securities International (Hong Kong) Limited acted as sole overall coordinator and placing agent on both Placings. The First Placing of 11,190,000 new H shares at HK$28.20 each was completed on September 17, 2026, followed by the Second Placing of 3,550,000 new H shares at HK$29.00 each on October 30, 2026. The Placings raised approximately HK$315.56 million and HK$102.95 million in gross proceeds, respectively, or approximately HK$418.51 million in aggregate (approximately HK$415.96 million in aggregate net proceeds). Both Placings were conducted under the same general mandate granted by shareholders at Xunzhong’s 2025 annual general meeting, and each was completed within one week of the signing of its placing agreement. Completing placings in consecutive months is relatively uncommon in the Hong Kong market, and doing so called on the technical depth of Dorsey’s Hong Kong Capital Markets team. Working closely with Xunzhong to understand its business needs and prepare the transaction documents, the team addressed in quick succession the remaining capacity under the general mandate, disclosure of the use of proceeds and the maintenance of Xunzhong’s public float, enabling both Placings to be completed seamlessly. “We are pleased to have advised Xunzhong on both Placings,” said Rachel Han, Partner and Co-Head of Dorsey’s Asia Capital Markets practice. “We appreciate the trust placed in our team and the close collaboration among all parties involved. We look forward to supporting Xunzhong as it continues to execute its growth strategy and pursue future capital markets opportunities.” Xunzhong is principally engaged in cloud-based communications services and enterprise digitalization services in the PRC. As disclosed in its announcements, the net proceeds of the First Placing are allocated to developing Xunzhong’s new computing power operation services business, while those of the Second Placing will be used to integrate model-as-a-service (MaaS) and AI agent capabilities into its existing cloud communications platform-as-a-service (PaaS) platform and software-as-a-service (SaaS) products. Approximately 55% of the net proceeds of the Second Placing will be used for computing power equipment upgrades for the MaaS system, approximately 35% for MaaS, PaaS and SaaS platform upgrades, and approximately 10% for working capital and general corporate purposes. With a single MaaS platform and shared computing power supporting its PaaS and SaaS offerings, Xunzhong intends for its MaaS, PaaS and SaaS capabilities to complement and reinforce one another, and to address customer needs from multiple angles, from embedding AI in customer communications and business workflows to maintaining stable performance at scale and keeping customer data within controlled environments. Partner and Co-Head of Dorsey’s Asia Capital Markets practice Rachel Han and Of Counsel in the Capital Markets and Corporate Compliance group Carlton Ng, along with Associate Kristy Ting, led the Dorsey Hong Kong Capital Markets & Corporate Compliance group in advising Xunzhong on both Placings.

Insights

Minnesota Consumer-Fraud Enforcement: Disclaimers Won’t Cure Deception, and Penalties Can Add Up

Misleading advertising claims can lead to costly consequences. In State of Minnesota ex rel. Ellison v. Wall & Associates, Inc., No. A25-2064, 2026 WL 3118291 (Minn. App. Oct. 19, 2026), the Minnesota Court of Appeals recently affirmed a bench trial verdict against a tax-relief company and two executives for violations of the Minnesota Consumer Fraud Act (“MCFA”) and the Minnesota Deceptive Trade Practices Act (“MDTPA”). The decision, which affirmed a substantial restitution and civil penalty judgment, underscores the broad power of the Minnesota Attorney General to act against deceptive sales practices. The decision also offers practical lessons for businesses seeking to reduce liability risks in consumer-facing communications. Background Wall & Associates (“W&A”), a Virginia-based tax-relief company, marketed assistance to taxpayers seeking relief from outstanding federal and state tax liabilities, often with offers in compromise—agreements to settle tax liabilities for less than the amount owed. In its extensive advertising campaigns, W&A represented that its average client received a 90% reduction in their tax debt, that it was a local company with Minnesota offices, that it provided legal services, and that it would “Solve ALL Tax Problems.” In reality, W&A’s promises bore little resemblance to what many clients received. Most of W&A’s clients saw just a 9.5% reduction in federal tax debt and 1.2% in state tax debt. W&A had no permanent Minnesota offices. And W&A provided neither legal representation nor assistance with filing tax returns—those services required referrals to separate firms for an additional fee. All the while, W&A clients paid upfront and recurring fees, including during periods when W&A did no work on their cases. Minnesota Attorney General Keith Ellison sued W&A, its founder and owner Ernest Kenneth Wall, and its president and CEO Patrick Mark Yates, alleging violations of, among other laws, the MCFA and the MDTPA. Following a 12-day bench trial, the district court determined that W&A violated the MCFA and MDTPA through its false and embellished advertising. The district court also held Wall and Yates individually liable for those violations because they directed, participated in, and acquiesced in the violations. The district court ordered injunctive relief, $2.7 million in restitution (with Wall and Yates jointly and severally liable for $1.3 million), and civil penalties of $786,517 against W&A, $415,500 against Wall, and $207,750 against Yates. The district court also awarded over $2.5 million in attorneys’ fees and costs to the state. W&A, Wall, and Yates appealed to the Minnesota Court of Appeals, which affirmed the district court’s decision on October 19, 2026. Although W&A, Wall, and Yates challenged the judgment on numerous grounds, several highlights of the decision provide important takeaways for consumer-facing businesses. Individual Reliance Is Not Required for Statutory Liability W&A argued that Attorney General Ellison had to prove a causal nexus between each violation of the MCFA and MDTPA and the injury to a particular consumer to establish liability. In W&A’s view, this required proof that each injured consumer had personally relied on W&A’s false representation. The Court of Appeals rejected this argument based on the MCFA’s and MDTPA’s plain language, which requires no proof of actual deception or confusion by consumers. The Court of Appeals finally pointed to the Minnesota Supreme Court’s decision in State v. Minnesota School of Business, Inc., which held that when a defendant’s misrepresentations are directed at and affected “a broad group of consumers, proof of direct individual reliance is not required to establish a causal nexus between MCFA violations and the harm suffered by consumers.” 935 N.W.2d 124, 135 (Minn. 2019). The Court of Appeals affirmed, however, that a causal nexus is necessary to support an award of damages under the MCFA and MDTPA. In making that determination, district courts look to various factors, including whether the misrepresentations were “longstanding, pervasive, and widespread in communications directed to consumers,” whether the seller intended and understood that consumers would rely on the misrepresentations, and whether the information was of a kind on which consumers would typically rely. The Court of Appeals’ decision continues Minnesota School of Business’s broad interpretation of liability under the MCFA and the MDTPA. Coordinated marketing campaigns to a “broad group of consumers” may expose businesses to MCFA and MDTPA liability without customer-by-customer proof of injury. That said, a causal nexus remains an element of an MCFA and MDTPA claim, and businesses involved in litigation should build a clear record at trial and on appeal showing how each of the relevant factors bears on the causal-nexus inquiry. Contractual Disclaimers Are Not an Automatic Defense to a Misleading Pitch W&A next argued that disclaimers in its client contracts prevented consumers from claiming they had been misled by its advertising. Reiterating that individual reliance is not required under the MCFA and MDTPA, the Court of Appeals held that a contractual disclaimer does not necessarily defeat a claim based on a conflicting oral representation. And on the facts of this case, the Court of Appeals agreed with the district court that W&A’s contractual disclaimers were insufficient given the extensive misrepresentations by W&A and the unequal bargaining power between it and its customers. This holding confirms that contractual disclaimers are not a cure-all for misleading advertising or sales practices. Businesses should review the entire customer journey, including pre-contract representations, as those representations may survive a contractual disclaimer to the contrary. And if faced with litigation, businesses should build a strong record, both at trial and on appeal, showing why any disclaimer is effective in context. The State Has Broad Authority to Seek Restitution W&A also challenged Attorney General Ellison’s authority to seek restitution under the state’s parens patriae authority to protect residents’ collective interests, arguing that injury to only 228 Minnesotans did not affect a sufficiently substantial segment of the population. The Court of Appeals rejected a simple headcount approach, instead explaining that the state had a legitimate interest in protecting residents’ economic well-being as a whole. In any event, the Court of Appeals held that if restitution was not appropriate under the state’s parens patriae authority, then it would still be appropriate under the Attorney General’s enforcement powers under Minn. Stat. § 8.31. The decision reinforces that the broader and more sustained the deceptive advertising, the stronger the case for restitution to protect Minnesotans’ economic interests. Civil Penalties Accrue Per Violation, Not Per Defendant The Court of Appeals finally rejected W&A’s claim that the Attorney General’s enforcement powers under Minn. Stat. § 8.31 permit only civil penalties of up to $25,000 for each defendant. Rather, the Court of Appeals explained that penalties are limited to $25,000 per violation. Multiple violations can therefore produce substantially greater penalties. The Court of Appeals also rejected the argument that restitution made penalties unnecessary: repaying consumers does not eliminate the need to address gains from deceptive conduct and deter future violations. Final Takeaways Align every consumer-facing communication. Broad and extensive marketing campaigns can expose businesses to stronger enforcement standards under the MCFA and MDTPA, making it critical that consumer communications remain accurate and consistent from the first advertisement through the final sale. Plan for layered enforcement exposure. Penalties under the MCFA and MDTPA can add up quickly: W&A, Wall, and Yates ultimately faced more than $6 million in civil penalties, restitution, and attorneys’ fees. The decision continues a line of Minnesota cases recognizing the Attorney General’s broad consumer-protection authority. Details matter. Although the Attorney General’s enforcement power is broad, it is not boundless. As the Court of Appeals explained, issues of causation, the effectiveness of contractual disclaimers, and the availability of restitution and civil penalties all turn on the specific facts of the case. Effective advocacy at trial and on appeal is critical to developing the facts relevant to liability and damages.

Event/Resource

Corporate Counsel Symposium 2026 Materials Hub

Materials Symposium Agenda Sessions 8:30 am - 9:30 am CT Session A: The Corporate Compass: Finding True North When Ethical Duties Conflict Philip Kaplan, Senior Legal Counsel, Howden Re Lucia Suljic, Vice President, Corporate Legal, Canon USA Nicole Stanton, Partner & Deputy General Counsel, Dorsey & Whitney LLP This panel addresses ethical obligations of in-house counsel, including balancing obligations and duties that may conflict with each other. How should a responsible in-house lawyer deal with those challenging situations? Rather than stick to an academic discussion, this panel will revolve around a series of practical scenarios that are designed to be realistic and timely, including situations where counsel is asked to represent both the company and an individual, how and when to disclose uncomfortable facts and inconvenient documents, issues involving changing firms and companies, and multijurisdictional practice. The panel will feature discussion from two experienced in-house lawyers and Dorsey’s Deputy General Counsel. Session B: Managing Rapid Regulatory Change in International Trade and Cross-Border Investment Nathan Brower, Executive Vice President, General Counsel, Nature’s Sunshine Greg Ogunsanya, Senior Vice President, General Counsel and Corporate Secretary, H.B. Fuller Kathryn Wood, Senior Vice President & General Counsel, DecoPac, Inc. Dave Townsend and Lawrence Ward, Dorsey & Whitney LLP This program is designed for attorneys advising on cross-border transactions, international trade, regulatory compliance, and corporate governance matters. Panelists will examine recent developments in U.S. trade and investment law and policy, as well as their impact on international collaborations, corporate compliance, and mergers and acquisitions. The discussion will explore how general counsel and in-house legal teams assess and manage evolving trade-related risks within their organizations. Particular focus will be given to developments during the first two years of the second Trump Administration, including changes in tariff policy, tariff refunds, export controls, economic sanctions, and national security reviews of foreign investment. Through a discussion of regulatory trends and practical case studies, attendees will gain a deeper understanding of the legal risks and compliance obligations associated with cross-border business activities, and hear about practical strategies for advising clients and managing compliance obligations in a rapidly changing trade and investment environment. 9:45 am - 10:45 am CT Session A: The Elon Musk Cases: What Tesla and Twitter Can Teach Your Board of Directors Loren Unterseher, Managing Partner, Oxbow Industries, LLC Shulamite White, Chief Legal Officer and Head of People, Motive Technologies Kirsten Schubert, Tom Swigert, and Jonathan Van Horn, Dorsey & Whitney LLP Recent cases involving Elon Musk and his businesses have had significant impact on principles governing board of directors’ fiduciary duties and corporate processes. This panel will examine recent litigation involving Elon Musk, Tesla, and Twitter, and its effects on the law governing the duties of directors and executives, including the executive compensation and director compensation processes, conflicts that may arise when a single executive has control over multiple businesses, and the ramifications of tweets or other public statements by an executive. Session B: All Eyes on DEI: Managing Diversity Efforts Amid Regulatory Scrutiny and Potential Litigation Maggie Dalton, Senior Commercial Attorney, Cargill; Board Co-Chair, Twin Cities Diversity in Practice Laura A. Vannelli, Legal Counsel, Mayo Clinic Susan Lorenc and Jack Sullivan, Dorsey & Whitney LLP The legal and regulatory landscape surrounding diversity, equity, and inclusion (DEI) initiatives has changed dramatically over the past two years. Law firms and legal departments are continuing to grapple with how to recruit, retain, and develop talent from a wide range of personal backgrounds, in a world where previously accepted recruiting and employment practices are facing increased scrutiny and litigation. This program will provide a practical overview of the current legal regime, including recent federal enforcement actions and litigation trends associated with DEI initiatives. Panelists will discuss practical ways in which organizations can pursue and retain legal talent and increase inclusion while minimizing legal, business, and reputational risk. 11:00 am - 12:00 pm CT Session A: Governance in an Age of Increasing Unpredictability James Chosy, Senior Executive Vice President and General Counsel, U.S. Bancorp Todd Hartman, Executive Vice President and Chief Legal and Risk Officer, Best Buy Co., Inc. Alan Rosselot, Associate General Counsel & Assistant Secretary, Delta Air Lines, Inc. Cam Hoang and Robert Rosenbaum, Dorsey & Whitney LLP More than ever, ensuring that boards are well-informed and forward-thinking is critical to a company’s success. Join our panel of corporate governance experts as they share their experiences advising boards through crisis and unpredictable events; capitalizing on, but also checking, disruptive technologies; and positioning the company to succeed in an environment of shifting government priorities. Session B: A Day in the Life of a Trademark, Copyright & Advertising Attorney: A Hypothetical Case Study Alexander Kim, Vice President and General Counsel, Binks Nate Whitaker, Chief Legal Officer and General Counsel, Crumbl Cathy Dahl and Tiffany Shimada, Dorsey & Whitney LLP What issues are companies facing daily while developing rights in intellectual property, protecting those rights, and staying in compliance with myriad potential issues related to advertising, social media, relationships with influencers, and environmental or governmental claims? This panel will feature two in-house counsel who are navigating these issues, utilizing a hypothetical case study, with the support of two Dorsey attorneys helping to develop a roadmap for meeting business objectives and minimizing the risk of claims. 12:00 pm - 1:15 pm CT Keynote Address Dr. Rebecca Heiss, Stress Physiologist Dr. Rebecca Heiss is a stress physiologist, author, and sought-after speaker who helps audiences transform fear and stress into fuel for greater performance and resilience. Her research has been recognized as “transformative” by the National Science Foundation, and she is the author of two books, Springboard and Instinct. Through her Fear(less) message, Rebecca inspires audiences with practical, science-based strategies to train our brains to work for us – not against us – and navigate change and uncertainty with greater confidence.

Insights

Observations on the SEC’s 2027 Examination Priorities

The SEC’s Division of Examinations (the “Division”) recently announced its examination priorities (“Exam Priorities”) for fiscal year 2027.1 Although many of the Division’s core areas of focus remain consistent with fiscal year 2026, the 2027 Exam Priorities include notable changes and refinements, which we discuss below, along with other key 2027 examination priorities. Dorsey Observations Renewed focus on economic conflicts of interest. After certain economic-incentive topics received less emphasis in the 2026 Exam Priorities2, the Division has again expressly identified economic conflicts as an examination focus. The 2027 Exam Priorities indicate that the Division will prioritize reviewing advisers’ fiduciary obligations relating to economic conflicts of interest raised by fee rebates, fee and expense calculations, cash management, quid pro quo arrangements, and deposits and withdrawals. Greater emphasis on private-fund practices. Building on the private-fund items in the 2026 Exam Priorities, the 2027 Exam Priorities indicate that the Division will assess private-fund disclosures and controls relating to investment allocations, leverage, affiliated service providers, and fees and expenses. The Division also identified investments in private companies through special purpose vehicles (“SPVs”) and loans provided by private funds and business development companies (“BDCs”) as products the Division will scrutinize. Advisers, particularly private-fund advisers, should evaluate whether their disclosures and compliance programs address these areas. Expanded focus on AI-related cybersecurity risks. While the 2026 Exam Priorities focused on advisers’ use of and representations regarding artificial intelligence (“AI”), the 2027 Exam Priorities specifically highlight AI-enabled cybersecurity threats, including AI-generated phishing and synthetic or “deepfake” voice and video used for social engineering. The shift signals that registrants should consider whether their cybersecurity policies and controls adequately address these evolving threats. New focus on proxy advisory firms. The 2027 Exam Priorities state that the Division will examine advisers that rely on proxy advisory firms, including how those advisers evaluate the firms’ recommendations, assess the bases for those recommendations, identify potential conflicts of interest, and determine whether that reliance satisfies applicable legal obligations. Advisers that rely on proxy advisory firms may wish to consider whether their compliance programs address these areas. Updated focus on Regulation S-P and Regulation S-ID. The 2026 Exam Priorities stated that the Division would engage firms during examinations regarding their progress in preparing incident response programs ahead of the compliance dates for the amendments to Regulation S-P and would examine compliance with the amended rule after those dates. The 2027 Exam Priorities indicate that examinations will focus on whether firms have developed, implemented, and maintained reasonably designed policies and procedures addressing administrative, technical, and physical safeguards to protect customer information and that, in accordance with the amended rule, staff will evaluate response program policies and procedures for unauthorized access to or use of customer information, including customer notification procedures and oversight of service providers. With respect to Regulation S-ID, the 2027 Exam Priorities indicate that examiners will assess whether firms are updating their Identity Theft Prevention Program to address emerging risks, such as those related to AI and stolen credentials. Advisers may wish to consider whether their compliance programs address these areas, as applicable. Summary of Other 2027 Examination Priorities Beyond the developments discussed above, many of the Division’s core examination priorities remain consistent with fiscal year 2026. These include investment adviser fiduciary obligations and compliance programs, examinations of never-examined and recently registered advisers, and cybersecurity and operational resiliency. The Exam Priorities are not exhaustive, and examinations will vary based on each registrant’s business, activities and risks. Advisers should consider the 2027 Exam Priorities in reviewing their compliance programs and preparing for potential examinations, including by: Reviewing risk disclosures and controls. The Division states that, when examining advisers to private funds, it will assess whether investment-related risk disclosures are consistent with fiduciary standards and whether compliance policies, procedures, and controls are designed to address both fund-level and investment-level risks. Reviewing disclosures on allocations, leverage, and affiliated service providers. The 2027 Exam Priorities identify disclosures related to certain investments and allocations, the use of debt and fund-level lines of credit, and the use of affiliated service providers as examples. Confirming the accuracy of fee and expense calculations. The Division states that it will assess the accuracy of fee and expense calculations at both the fund and investment levels, and it identifies fee rebates, cash management, quid pro quo arrangements, deposits, and withdrawals as areas in which economic conflicts of interest may affect the impartiality of advice. Reviewing recommendations of illiquid or hard-to-trade products. The Division states that it will prioritize advisers that recommend products that are difficult to trade, have unusual features, or are illiquid, including loans provided by private funds or BDCs and investments in private companies through SPVs. Confirming that the compliance program is implemented and reviewed. The Division states that it will review compliance program components such as marketing, valuation, and custody, as appropriate, and will typically analyze the annual compliance review. It will also focus on compliance practices when advisers have started advising new asset classes or clients or grown through mergers or acquisitions. 1 SEC Division of Examinations 2027 Examination Priorities. 2 See Dorsey’s Client Alert on the SEC’s fiscal year 2026 exam priorities.